Biogen Full Royalty Sample Clauses

Biogen Full Royalty. As partial consideration for the rights granted to Biogen hereunder, subject to the provisions of this Section 6.6.1 and Section 6.6.2, Biogen will pay to Ionis royalties on a Collaboration Program-by-Collaboration Program basis on Annual worldwide Net Sales of Products included in the applicable Collaboration Program sold by Biogen, its Affiliates or Sublicensees, on a country-by-country basis, in each case in the amounts as follows in Table 3 below (the “Biogen Full Royalty”): Table 3 Royalty Tier Annual Worldwide Net Sales of Products for the applicable Collaboration Program Royalty Rate for [***] Collaboration Program Royalty Rate for [***] Collaboration Program 1 For the portion of Annual Worldwide Net Sales < $[***] [***]% [***]% 2 For the portion of Annual Worldwide Net Sales > $[***] but < $[***] [***]% [***]% 3 For the portion of Annual Worldwide Net Sales > $[***] but < $[***] [***]% [***]% 4 For the portion of Annual Worldwide Net Sales > $[***] but < $[***] [***]% [***]% 5 For the portion of Annual Worldwide Net Sales > $[***] but < $[***] [***]% [***]% 6 For the portion of Annual Worldwide Net Sales > $[***] but < $[***] [***]% [***]% 7 For the portion of Annual Worldwide Net Sales > $[***] [***]% [***]% Annual worldwide Net Sales of Products will be calculated by [***].
Sample 1
AutoNDA by SimpleDocs
Biogen Full Royalty. As partial consideration for the rights granted to Biogen hereunder, subject to the provisions of this Section 6.6.1 and Section 6.6.2, Biogen will pay to Ionis royalties on a Collaboration Program-by-Collaboration Program basis, on Annual worldwide Net Sales of Products included in the applicable Collaboration Program sold by Biogen, its Affiliates or Sublicensees, on a country-by-country basis, in each case in the amounts as follows in Table 3 below (the “Biogen Full Royalty”): Table 3 Royalty Tier Annual Worldwide Net Sales of Products Royalty Rate 1 For the portion of Annual worldwide Net Sales < $[***] [***]%
Sample 1

Related to Biogen Full Royalty

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Royalty Payment In partial consideration of the grant of rights to Schering by ICN under this Agreement, Schering shall pay ICN a royalty in the following amount:

  • Earned Royalty In addition, Alnylam will pay Stanford earned royalties on Net Sales as follows:

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Royalty Payments (i) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate.

  • Royalty 8.1 In consideration of the rights granted under clause 2, the Licensee shall pay to the Licensor royalties, on each twelve month time period, first calculated from the date of execution of this Agreement, and calculated on a scale as follows:

  • Earned Royalties Subject to of Article 7 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to one and [*****] of the Net Invoice Value of Trademarked Products Sold by Licensee (the "Royalties"). The Royalties shall be remitted in accordance with Section 7.4 of this Agreement. 6.2

  • License Fee Controlled Affiliate will pay to BCBSA a fee for this License determined pursuant to the formula(s) set forth in Exhibit B.

  • One Royalty No more than one royalty payment shall be due with respect to a sale of a particular Licensed Product. No multiple royalties shall be payable because any Licensed Product, or its manufacture, sale or use is covered by more than one Valid Claim.

  • Third Party Royalties Each party shall be responsible for all of its own costs of commercializing Products or licensing Intellectual Property Rights, including any payments to Third Parties for work done by such Third Parties or for licenses necessary for the manufacture, sale, or use of Products by a party or its Affiliates or sublicensees.

Time is Money Join Law Insider Premium to draft better contracts faster.